Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1
- PMID: 1570514
- DOI: 10.1126/science.1570514
Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1
Abstract
Protein tyrosine phosphorylation is a common mechanism of signaling in pathways that regulate T cell receptor-mediated cell activation, cell proliferation, and the cell cycle. Because human immunodeficiency virus (HIV) is though to affect normal cell signaling, tyrosine phosphorylation may be associated with HIV cytopathicity. In both HIV-infected cells and transfected cells that stably express HIV envelope glycoproteins undergoing HIVgp41-induced cell fusion, a 30-kilodalton protein was phosphorylated on tyrosine with kinetics similar to those of syncytium formation and cell death. When tyrosine phosphorylation was inhibited by the protein tyrosine kinase inhibitor herbimycin A, envelope-mediated syncytium formation was coordinately reduced. These studies show that specific intracellular signals, which apparently participate in cytopathicity, are generated by HIV and suggest strategies by which the fusion process might be interrupted.
Similar articles
-
Protein tyrosine kinase activation provides an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal antibody induced cell fusion mediated by HIV gp160.Med Microbiol Immunol. 1997 Oct;186(2-3):115-23. doi: 10.1007/s004300050053. Med Microbiol Immunol. 1997. PMID: 9403839
-
Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.Proc Natl Acad Sci U S A. 1990 Oct;87(19):7722-6. doi: 10.1073/pnas.87.19.7722. Proc Natl Acad Sci U S A. 1990. PMID: 2217205 Free PMC article.
-
Infection of human T lymphoid cells by human herpesvirus 6 is blocked by two unrelated protein tyrosine kinase inhibitors, biochanin A and herbimycin.AIDS Res Hum Retroviruses. 1996 Nov 20;12(17):1629-34. doi: 10.1089/aid.1996.12.1629. AIDS Res Hum Retroviruses. 1996. PMID: 8947298
-
Potential mechanisms for the cytopathic properties of HIV.AIDS. 1989 Nov;3(11):683-94. doi: 10.1097/00002030-198911000-00001. AIDS. 1989. PMID: 2575911 Review. No abstract available.
-
Human immunodeficiency virus type 1-associated CD4 downmodulation.Adv Virus Res. 1994;44:203-66. doi: 10.1016/s0065-3527(08)60330-9. Adv Virus Res. 1994. PMID: 7817874 Free PMC article. Review.
Cited by
-
Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.J Exp Med. 1997 Jul 7;186(1):7-16. doi: 10.1084/jem.186.1.7. J Exp Med. 1997. PMID: 9206992 Free PMC article.
-
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.Microbiol Rev. 1996 Jun;60(2):386-406. doi: 10.1128/mr.60.2.386-406.1996. Microbiol Rev. 1996. PMID: 8801439 Free PMC article. Review.
-
Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1.Arch Virol. 1995;140(7):1181-94. doi: 10.1007/BF01322745. Arch Virol. 1995. PMID: 7544112
-
The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events.EMBO J. 1993 Dec 15;12(13):5105-12. doi: 10.1002/j.1460-2075.1993.tb06205.x. EMBO J. 1993. PMID: 8262054 Free PMC article.
-
Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells.J Virol. 2002 Nov;76(22):11584-95. doi: 10.1128/jvi.76.22.11584-11595.2002. J Virol. 2002. PMID: 12388719 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources